Pressure Biosciences Executives

PBIODelisted Stock  USD 0.49  0.00  0.00%   
Pressure Biosciences employs about 12 people. The company is managed by 4 executives with a total tenure of roughly 24 years, averaging almost 6.0 years of service per executive, having 3.0 employees per reported executive. Analysis of Pressure Biosciences' management performance can provide insight into the firm performance.
Richard Schumacher  CEO
Founder, CEO and President Acting CFO, Treasurer, Secretary, Clerk and Director
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Pressure Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.9258) % which means that it has lost $0.9258 on every $100 spent on assets. This is way below average. Pressure Biosciences' management efficiency ratios could be used to measure how well Pressure Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Pressure Biosciences Workforce Comparison

Pressure Biosciences is regarded fifth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 295. Pressure Biosciences holds roughly 12.0 in number of employees claiming about 4% of equities under Health Care industry.

Pressure Biosciences Notable Stakeholders

A Pressure Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pressure Biosciences often face trade-offs trying to please all of them. Pressure Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pressure Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Richard SchumacherFounder, CEO and President Acting CFO, Treasurer, Secretary, Clerk and DirectorProfile
ScD TingVP EngineeringProfile
Alexander LazarevChief OfficerProfile
John HollisterDirector MarketingProfile

About Pressure Biosciences Management Performance

The success or failure of an entity such as Pressure Biosciences often depends on how effective the management is. Pressure Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pressure management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pressure management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp. Pressure Biosciences operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 12 people.
The data published in Pressure Biosciences' official financial statements typically reflect Pressure Biosciences' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Pressure Biosciences' quantitative information. For example, before you start analyzing numbers published by Pressure accountants, it's essential to understand Pressure Biosciences' liquidity, profitability, and earnings quality within the context of the Life Sciences Tools & Services space in which it operates.

Pressure Biosciences Workforce Analysis

Traditionally, organizations such as Pressure Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pressure Biosciences within its industry.

Pressure Biosciences Manpower Efficiency

Return on Pressure Biosciences Manpower

Revenue Per Employee166.9K
Revenue Per Executive500.6K
Net Loss Per Employee1.7M
Net Loss Per Executive5M
Working Capital Per Employee766.5K
Working Capital Per Executive2.3M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Pressure OTC Stock

If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Transaction History
View history of all your transactions and understand their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stocks Directory
Find actively traded stocks across global markets